Journal Report

EJNMMI RESEARCH

Download PDF
Journal Information
Journal Title
EJNMMI RESEARCH
Publisher
SPRINGER
ISSN
2191-219X
E-ISSN
2191-219X
Database
Clarivate
Domain
Not available
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Long-term effects of [177Lu]Lu-PSMA therapy on the kidneys based on cumulative absorbed dose
Zachary Ells, Muyu Wu, Linus Hempel et al.
2026-10-27
Preclinical evaluation of PD-L1 targeted radiotherapy in a xenograft mouse model of triple-negative breast cancer
Jonathan Moye, Hailey A. Houson, Adriana V. F. Massicano et al.
2026-10-26
Current practices and access to cardiac bone scintigraphy for diagnosing transthyretin cardiac amyloidosis: results of a large national survey
Fabien Hyafil, Silvia Oghina, Damien Legallois et al.
2026-10-26
Type of dialysis may influence the prognostic value of myocardial perfusion imaging in end stage renal disease: an observational [13N]NH3 PET/CT study
Christian Wenning, Thekla Maria Gosmann, Alexis Vrachimis et al.
2026-10-24 Vol. 16 Issue 1
Cross sectional, test-retest and longitudinal changes of relative cerebral blood flow in Parkinson's disease
Minyoung Oh, My Jonasson, Vera Kerstens et al.
2026-10-20
Comparative evaluation of carbohydrate-based PET tracers for Aspergillus fumigatus imaging
Jianhao Lai, Swati Shah, Neysha Martinez-Orengo et al.
2026-10-15
Ongoing atrial fibroblast activation after catheter ablation for atrial fibrillation: insights from [68Ga]Ga-FAPI-04 PET/CMR
Feng Yin, Boning Yang, Wei Zhang et al.
2026-10-14
Nonclinical safety assessment for therapeutic radiopharmaceutical development: a scoping review of rodent studies
Jong Il Shin, Jin Young Baik, Yiseul Choi et al.
2026-10-14
Detecting pathological response to neoadjuvant therapy in rectal cancer by [18F]-FDG and [18F]-FAPI-42 PET/MRI
Weicheng Zhou, Haode Shen, Qiang Ma et al.
2026-10-13
Targeting EGFR and HER2 in bladder cancer: receptor profiling and therapeutic potential of 213bismuth alpha-particle therapy
Ece Erder, Satyendra Kumar Singh, Lu Lucy Xu et al.
2026-10-13
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 27, 2026 17:50